03/13/2026
🐶 Dogs with B-Cell Lymphoma Needed for Clinical Trial 🧬
The Clinical Trials team at the University of Missouri Veterinary Health Center is enrolling dogs for a study evaluating a BTK inhibitor (BI705564) for canine B-cell lymphoma.
Eligible dogs may receive innovative cancer treatment, and study-related costs are covered by the trial sponsor.
If your dog has untreated B-cell lymphoma, they may qualify.
📲 Scan the QR code to learn more about eligibility or contact our team.
📞 573-882-7821
📧 [email protected]